CNS Progression
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease (NCT04541407) | University of Colorado, Denver | 2020-10-29 |
Track CNS Progression automatically
Every clearance here is in the API, with alerts when new ones post.